Shakeup at NIAID, USA
Trump Administration Replaces Top Scientists of Covid-19 Era Amid Broader Crackdown
Collected Photo
A major overhaul is underway at the US National Institute of Allergy and Infectious Diseases (NIAID), where eight of the top ten leadership positions have been cleared out since President Donald Trump took office for his second term.
Sources within the agency confirm that three additional senior officials were recently given an ultimatum: accept reassignments outside the institute or resign. This follows the high-profile ousting of Jeanne Marrazzo last year, who had stepped in to lead the NIAID after Anthony Fauci’s retirement in 2022.
Targeting the Fauci Era
The sweeping changes represent a near-total dismantling of the agency's veteran leadership. Seven of the eight displaced officials served under Fauci during his 38-year tenure. Fauci and his inner circle have long faced intense scrutiny from President Trump and Republican lawmakers over government-mandated public health policies implemented during the COVID-19 pandemic.
The pressure on the agency has intensified over the past month, as the Trump administration has begun pursuing formal charges against scientists closely linked to Fauci who oversaw COVID-19 research.
Concerns Over Political Influence
Forcing out career scientists during a presidential transition is a highly unusual move for the National Institutes of Health (NIH), the NIAID's parent organization. Because these positions are traditionally insulated from political shifts, the aggressive restructuring has sparked deep concern within the medical community.
Critics worry that the shakeup threatens the stability of an institution managing a $6.6 billion annual budget. Betty Diamond, an immunologist at the Feinstein Institutes for Medical Research, warned that abrupt leadership changes risk damaging institutional trust.
"When you’ve spent years to put in place certain kinds of programmes and earn the trust and admiration of the scientific community, disruption for the sake of disruption is not useful," Diamond said.
The Administration's Stance
While agency staff spoke on the condition of anonymity due to fears of retaliation, the administration has defended its broader vision for the network of research centers.
Andrew Nixon, a spokesperson for the Department of Health and Human Services, declined to comment on specific personnel decisions but stated that the department remains dedicated to maintaining robust leadership. Meanwhile, NIH Director Jayanta Bhattacharya has publicly advocated for major reforms, asserting that the agency must pivot away from what he characterizes as "politicized" science.
Veteran Scientists Demoted as NIH Shifts Focus Away from Pandemic Preparedness
The ongoing overhaul at the US National Institute of Allergy and Infectious Diseases (NIAID) has claimed three more veteran officials, cementing a near-total purge of the era led by former director Anthony Fauci.
The officials forced out in this latest wave are:
Daniel Rotrosen: The head scientist for the Division of Allergy, Immunology, and Transplantation, who has served in his role for nearly 30 years.
Kelly Poe: Director of the Division of Extramural Activities, responsible for managing the institute's extensive grant policies and funding.
Andrea Wurster: Deputy director of the Division of Extramural Activities.
According to internal staff, no official reasons were provided for the sudden reshuffling. Rotrosen was offered a reassignment within an NIH strategic initiatives office, while Poe and Wurster were reassigned to the National Institute on Minority Health and Health Disparities (NIMHD).
"Major Demotions" Inside the Agency
The forced transfers are being viewed internally as severe downgrades. Jennifer Troyer, a former NIH operations director who resigned last December over concerns of political meddling, characterized the reassignments as "major demotions."
The contrast in institutional scale is stark: NIAID’s budget is more than ten times larger than that of the NIMHD—an agency the Trump administration has twice attempted to dismantle, only for it to be saved by Congress.
Dismantling the Fauci Legacy
The leadership purge aligns with a fundamental restructuring of the agency's scientific priorities. In an internal meeting, NIH Director Jayanta Bhattacharya outlined a new directive to pivot the NIAID away from long-standing programs established under Fauci.
The new administration's strategy focuses on:
Prioritizing infectious diseases actively impacting the United States today, de-emphasizing proactive research into future pandemic preparedness, scaling back funding for HIV/AIDS research and biodefense and increasing the focus on basic immunology.
This shift follows the removal of division chiefs last year who oversaw microbiology and HIV/AIDS research, signaling a definitive end to the agency's previous scientific roadmap.